Delfi Liquid Biopsy Shows Promise for Reducing Lung Cancer Deaths
- Friday, August 20, 2021, 7:12
- Business
- Add a comment
BALTIMORE and PALO ALTO, Calif., Aug. 20, 2021 /PRNewswire/ — A novel machine learning based blood testing technology that could help to increase detection of early-stage lung cancer demonstrated promising results in a study published in Nature Communications1. Delfi Diagnostics Inc.’s…
About the Author
adminasapcorp has written 41828 stories on this site.